262 related articles for article (PubMed ID: 467918)
1. Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease.
Holan KR; Holzbach RT; Hermann RE; Cooperman AM; Claffey WJ
Gastroenterology; 1979 Oct; 77(4 Pt 1):611-7. PubMed ID: 467918
[TBL] [Abstract][Full Text] [Related]
2. [Nucleation time and lithogenic index in obese patients and in patients with cholecystolithiasis].
Janowitz P; Wechsler JG; Swobodnik W; Fischer S; Förstner J; Ditschuneit H
Z Gastroenterol; 1988 Dec; 26(12):750-4. PubMed ID: 3245253
[TBL] [Abstract][Full Text] [Related]
3. Increased activity in the biliary Con A-binding fraction accounts for the difference in crystallization behavior in bile from Chilean gallstone patients compared with Dutch gallstone patients.
Miquel JF; Van Der Putten J; Pimentel F; Mok KS; Groen AK
Hepatology; 2001 Feb; 33(2):328-32. PubMed ID: 11172333
[TBL] [Abstract][Full Text] [Related]
4. Solubility of cholesterol in the crystal-free gallbladder bile of gallstone patients.
Jüngst D; Gussmann E; Zündt B; Meyer G; Jüngst C; Del Pozo R; Fischer S
J Lab Clin Med; 2004 Sep; 144(3):134-40. PubMed ID: 15454882
[TBL] [Abstract][Full Text] [Related]
5. Human gallbladder mucin accelerates nucleation of cholesterol in artificial bile.
Levy PF; Smith BF; LaMont JT
Gastroenterology; 1984 Aug; 87(2):270-5. PubMed ID: 6428962
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol crystallization in human gallbladder bile: relation to gallstone number, bile composition, and apolipoprotein E4 isoform.
Van Erpecum KJ; Van Berge-henegouwen GP; Eckhardt ER; Portincasa P; Van De Heijning BJ; Dallinga-Thie GM; Groen AK
Hepatology; 1998 Jun; 27(6):1508-16. PubMed ID: 9620320
[TBL] [Abstract][Full Text] [Related]
7. Supersaturated bile from obese patients without gallstones supports cholesterol crystal growth but not nucleation.
Whiting MJ; Watts JMcK
Gastroenterology; 1984 Feb; 86(2):243-8. PubMed ID: 6690352
[TBL] [Abstract][Full Text] [Related]
8. [Effect of hypolipidemic treatment on the composition of bile and the risk or cholesterol gallstone disease].
Zák A; Zeman M; Hrubant K; Vecka M; Tvrzická E
Cas Lek Cesk; 2007; 146(1):24-34. PubMed ID: 17310581
[TBL] [Abstract][Full Text] [Related]
9. The physical chemistry of cholesterol solubility in bile. Relationship to gallstone formation and dissolution in man.
Carey MC; Small DM
J Clin Invest; 1978 Apr; 61(4):998-1026. PubMed ID: 659586
[TBL] [Abstract][Full Text] [Related]
10. Biliary proteins. Unique inhibitors of cholesterol crystal nucleation in human gallbladder bile.
Holzbach RT; Kibe A; Thiel E; Howell JH; Marsh M; Hermann RE
J Clin Invest; 1984 Jan; 73(1):35-45. PubMed ID: 6690482
[TBL] [Abstract][Full Text] [Related]
11. [The possibility of prediction of cholesterol saturation of gallbladder bile].
Han TQ
Zhonghua Wai Ke Za Zhi; 1990 May; 28(5):285-8, 318. PubMed ID: 2086098
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of cholesterol gallstone disease.
Méndez-Sánchez N; Cárdenas-Vázquez R; Ponciano-Rodríguez G; Uribe M
Arch Med Res; 1996; 27(4):433-41. PubMed ID: 8987174
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a potent nucleating factor in the gallbladder bile of patients with cholesterol gallstones.
Burnstein MJ; Ilson RG; Petrunka CN; Taylor RD; Strasberg SM
Gastroenterology; 1983 Oct; 85(4):801-7. PubMed ID: 6884705
[TBL] [Abstract][Full Text] [Related]
14. Biliary proteins and their redox status changes in gallstone patients.
Grattagliano I; Wang DQ; Di Ciaula A; Diogo CV; Palasciano G; Portincasa P
Eur J Clin Invest; 2009 Nov; 39(11):986-92. PubMed ID: 19656169
[TBL] [Abstract][Full Text] [Related]
15. [Cholesterol gallstone pathogenesis].
Méndez N; Uribe M; Jessurun J; Uscanga L
Rev Invest Clin; 1990 Jul; 42 Suppl():53-7. PubMed ID: 19256135
[TBL] [Abstract][Full Text] [Related]
16. Effect of apolipoprotein E polymorphism on bile lipid composition and the formation of cholesterol gallstone.
Hasegawa K; Terada S; Kubota K; Itakura H; Imamura H; Ohnishi S; Aoki T; Ijichi M; Saiura A; Makuuchi M
Am J Gastroenterol; 2003 Jul; 98(7):1605-9. PubMed ID: 12873586
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a nucleation defect in bile from gallstone patients.
Gallinger S; Harvey PR; Strasberg SM
Hepatology; 1984; 4(5 Suppl):177S-179S. PubMed ID: 6479877
[TBL] [Abstract][Full Text] [Related]
18. The effects of the 3-hydroxy, 3-methylglutaryl coenzyme A reductase inhibitor pravastatin on bile composition and nucleation of cholesterol crystals in cholesterol gallstone disease.
Smit JW; van Erpecum KJ; Renooij W; Stolk MF; Edgar P; Doornewaard H; Vanberge-Henegouwen GP
Hepatology; 1995 Jun; 21(6):1523-9. PubMed ID: 7768495
[TBL] [Abstract][Full Text] [Related]
19. The effect of ursodeoxycholic acid on nucleation time in patients with solitary or multiple gallbladder stones.
Tudyka J; Wechsler JG; Mason R; Maier C
Am J Gastroenterol; 1994 Aug; 89(8):1206-10. PubMed ID: 8053436
[TBL] [Abstract][Full Text] [Related]
20. Effects of a concanavalin A-binding biliary glycoprotein on nucleation time of gallbladder bile.
Nakano A; Masuzawa S; Ogura K; Fukazawa S; Nakamoto K; Sekido H; Fukushima T; Tsuchiya S
Gastroenterol Jpn; 1990 Feb; 25(1):88-92. PubMed ID: 2307338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
